Fridriksdottir Hafrun
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Fridriksdottir Hafrun. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| TEVJF | Executive VP, Global R&D | Sale | 130,000 | $8.22 | $1,068,600 | May 17, 2022 |
| TEVJF | Executive VP, Global R&D | Option Exercise | 51,488 | — | — | Mar 7, 2022 |
| TEVJF | Executive VP, Global R&D | Sale | 7,590 | $8.14 | $61,783 | Feb 28, 2022 |
| TEVJF | Executive VP, Global R&D | Sale | 6,116 | $9.06 | $55,411 | Feb 9, 2022 |
| TEVJF | Executive VP, Global R&D | Sale | 50,860 | $9.95 | $506,057 | Aug 10, 2021 |
| TEVJF | Executive VP, Global R&D | Option Exercise | 37,884 | — | — | May 11, 2021 |
| TEVJF | Executive VP, Global R&D | Option Exercise | 18,905 | — | — | Mar 4, 2021 |
| TEVJF | Executive VP, Global R&D | Sale | 50,000 | $10.82 | $541,000 | Mar 2, 2021 |
| TEVJF | Executive VP, Global R&D | Option Exercise | 21,682 | — | — | Mar 1, 2021 |
| TEVJF | Executive VP, Global R&D | Sale | 2,098 | $11.12 | $23,330 | Feb 14, 2021 |
| TEVJF | Executive VP, Global R&D | Sale | 23,639 | $12.69 | $299,979 | Feb 9, 2021 |
| TEVJF | Executive VP, Global R&D | Sale | 134 | $7.16 | $959 | Mar 17, 2020 |
| TEVJF | Executive VP, Global R&D | Sale | 8,825 | $12.14 | $107,136 | Feb 14, 2020 |
| TEVJF | Executive VP, Global R&D | Sale | 5,544 | $12.27 | $68,025 | Feb 9, 2020 |
| TEVJF | Executive VP, Global R&D | Option Exercise | 4,640 | — | — | Dec 31, 2019 |
| TEVJF | Executive VP, Global R&D | Sale | 4,310 | $10.49 | $45,212 | Nov 30, 2019 |
| TEVJF | Executive VP, Global R&D | Sale | 263 | $16.63 | $4,374 | Mar 18, 2019 |
| TEVJF | Executive VP, Global R&D | Sale | 409 | $16.88 | $6,904 | Mar 4, 2019 |
| TEVJF | Executive VP, Global R&D | Option Exercise | 5,353 | — | — | Feb 14, 2019 |
| TEVJF | Executive VP, Global R&D | Option Exercise | 4,640 | — | — | Jan 2, 2019 |
| TEVJF | Executive VP, Global R&D | Option Exercise | 2,711 | — | — | Nov 30, 2018 |
| TEVJF | Executive VP, Global R&D | Option Exercise | 747 | — | — | Mar 19, 2018 |
| TEVJF | Executive VP, Global R&D | Tax Withholding | 1,155 | $19.38 | $22,384 | Mar 4, 2018 |
| 0001578845 | SVP, GLOBAL R&D | Award / Grant | 1,269 | $197.05 | $250,056 | May 9, 2014 |
| 0001578845 | SVP, GLOBAL R&D | Award / Grant | 5,645 | — | — | Oct 1, 2013 |
| 0000884629 | Sr VP, Global Generics R&D | Award / Grant | 4,318 | — | — | Sep 30, 2013 |
| 0000884629 | Sr VP,Global Generics R&D | Award / Grant | 1,727 | — | — | Mar 6, 2013 |